scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1026781931 |
P356 | DOI | 10.1038/LEU.2014.217 |
P932 | PMC publication ID | 4320294 |
P698 | PubMed publication ID | 25036192 |
P5875 | ResearchGate publication ID | 264632887 |
P50 | author | Dolors Colomer | Q43096016 |
Josep Nomdedeu | Q50238034 | ||
Gareth Gerrard | Q54397742 | ||
Anni Aggerholm | Q57318917 | ||
Giovanni Martinelli | Q90955283 | ||
Claude Preudhomme | Q30170087 | ||
Andreas Hochhaus | Q37829812 | ||
Nicholas Cross | Q42628914 | ||
P2093 | author name string | M Jansson | |
L Wang | |||
F Lin | |||
L Foroni | |||
G Wilson | |||
D-W Kim | |||
G Romeo | |||
L Deprez | |||
D Wren | |||
E Wilkinson | |||
R Ganderton | |||
T Lange | |||
H Andrikovics | |||
A Bench | |||
A Kizilors | |||
B Izzo | |||
B Milner | |||
D A Nymoen | |||
E Gineikienė | |||
E O Leibundgut | |||
F Daraio | |||
G Barbany | |||
G Mitterbauer-Hohendanner | |||
G Nickless | |||
H El Housni | |||
H Emons | |||
H Pfeifer | |||
H Schimmel | |||
H White | |||
J Farrugia | |||
J Ziermann | |||
J-M Cayuela | |||
K M Polakova | |||
K Raudsepp | |||
K Zoi | |||
L Fletcher | |||
M C Müller | |||
M Catherwood | |||
M Nagar | |||
N Boeckx | |||
P A Merle | |||
P Corbisier | |||
P Johnels | |||
P Waits | |||
R Talmaci | |||
R Zadro | |||
S Akiki | |||
S Chudleigh | |||
S Dulucq | |||
S Hayette | |||
S Mazoua | |||
S McCarron | |||
S Trapmann | |||
T Clench | |||
T Jurcek | |||
T Lion | |||
T Pajič | |||
T Sacha | |||
T Touloumenidou | |||
U Ozbek | |||
V H J Van der Velden | |||
V Hall | |||
V Kairisto | |||
P2860 | cites work | Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia | Q43043759 |
Estimating the uncertainty of stability for matrix CRMs | Q43672332 | ||
Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia | Q43971962 | ||
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia | Q44611047 | ||
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. | Q53042357 | ||
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. | Q53098953 | ||
Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale. | Q53114641 | ||
Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease. | Q54331600 | ||
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories | Q58023925 | ||
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. | Q31012437 | ||
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia | Q34620246 | ||
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. | Q35134983 | ||
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. | Q35561038 | ||
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results | Q35849776 | ||
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. | Q37026032 | ||
Harmonization of molecular monitoring of CML therapy in Europe | Q37587749 | ||
Standardisation of molecular monitoring for chronic myeloid leukaemia | Q37644010 | ||
Chronic myelogenous leukemia: monitoring response to therapy | Q37848207 | ||
Standardized definitions of molecular response in chronic myeloid leukemia. | Q38002704 | ||
BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia | Q38117928 | ||
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. | Q39665907 | ||
Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations | Q40095759 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 369-376 | |
P577 | publication date | 2014-07-18 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR | |
P478 | volume | 29 |
Q37000029 | An international comparability study on quantification of mRNA gene expression ratios: CCQM-P103.1. |
Q40429248 | Clarity™ digital PCR system: a novel platform for absolute quantification of nucleic acids |
Q28066148 | Current developments in molecular monitoring in chronic myeloid leukemia |
Q35107472 | DNA copy number concentration measured by digital and droplet digital quantitative PCR using certified reference materials |
Q26745594 | Deep molecular responses for treatment-free remission in chronic myeloid leukemia |
Q89359928 | Development and evaluation of armored RNA-based standards for quantification of BCR-ABL1p210/p190 fusion gene transcripts |
Q64067404 | Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials |
Q91857161 | Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR? |
Q42353330 | Digital PCR, a technique for the future |
Q28079008 | Digital polymerase chain reaction for characterisation of DNA reference materials |
Q51821011 | Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation. |
Q39401910 | Influence of primer & probe chemistry and amplification target on reverse transcription digital PCR quantification of viral RNA. |
Q90393398 | International external quality assurance of JAK2 V617F quantification |
Q35603605 | Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. |
Q38481945 | Molecular genetic evaluation of myeloproliferative neoplasms |
Q39027724 | Molecular monitoring in chronic myeloid leukemia-how low can you go? |
Q38392702 | Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization |
Q37696776 | Molecular techniques for the personalised management of patients with chronic myeloid leukaemia |
Q95642294 | Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances |
Q38762631 | Present and future of molecular monitoring in chronic myeloid leukaemia |
Q38757317 | Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target. |
Q92284305 | Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 |
Q40641203 | Synthetic certified DNA reference material for analysis of human erythropoietin transgene and transcript in gene doping and gene therapy. |
Q36094092 | The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis |
Q98177625 | Validation of Droplet Digital Polymerase Chain Reaction for Salmonella spp. Quantification |
Q40404105 | Validation of a digital PCR method for quantification of DNA copy number concentrations by using a certified reference material |
Search more.